MDS Pharma Services names Dominique Gerbet director, business development at Paris, France facility

(July 5, 2001; Paris, France) — MDS Pharma Services is pleased to announce that Dominique Gerbet, is now the director of the business development at its Paris, France clinical research site. In this role, Dominique Gerbet will be responsible for business development activities focusing on phases IIb, III, and IV of clinical development for France, Switzerland and the Benelux.

Dominique Gerbet has an extensive professional background, which includes experience in the pharmaceutical industry. As a pharmacist, he held various positions within a contract research organization including sales representative, account manager, marketing manager, and sales manager.

Dominique Gerbet will join the other members of the global clinical research development French business development team Marielle Miribel and Aude Benoit-Cattin.

"We are pleased to have Dominque join our business development team," said Anne-Marie Masquelier, general manager, MDS Pharma Services, southern Europe. "He brings a wealth of experience to the position and will be able to provide our customers with extensive knowledge of the French healthcare system in support of their global trials."

MDS Pharma Services is a global leader in clinical research services, from feasibility through regulatory submission and post-marketing studies, working diligently to customize these services. With facilities spanning four continents, each regional office is staffed with experts who bring their unique insights into the local healthcare system. MDS Pharma Services is a clinical research partner who thinks strategically about projects, anticipates clients’ needs, and rapidly delivers accurate results.

MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities in more than 18 countries, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process: discovery, preclinical, early clinical research (phases I-IIa), bioanalytical, global clinical research (phases IIb-IV), and central lab.

MDS Pharma Services is part of MDS Inc. (TSE: MDS; NYSE: MDZ), an international health and life sciences company. In many of its products and services, it is among the largest and most respected companies in the world. At MDS, the focus is on fighting disease. It does this by providing laboratory testing, imaging products, research services to speed discovery and development of new drugs, therapy systems for planning and delivery of cancer treatments, analytical instruments to assist in the development of new drugs, and medical/surgical supplies. MDS employs more than 10,000 highly skilled people in its global operations on five continents. Detailed information about the company is available at the MDS Web site at www.mdsintl.com or by calling 1-888-MDS-7222, 24 hours a day.